Royal Bank of Canada
ETON icon

Royal Bank of Canada’s Eton Pharmaceutcials ETON Stock Holding History

Royal Bank of Canada’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
13
-1,005
-99% -$17.6K ﹤0.01% 7277
2025
Q4 		$17K Sell
1,018
-478,175
-100% -$8.41M ﹤0.01% 6134
2025
Q3 		$10.4M Buy
479,193
+474,128
+9,361% +$7.87M ﹤0.01% 2125
2025
Q2 		$72K Buy
5,065
+3,436
+211% +$54.3K ﹤0.01% 5760
2025
Q1 		$22K Buy
1,629
+877
+117% +$13.3K ﹤0.01% 5877
2024
Q4 		$10K Buy
752
+477
+173% +$4.84K ﹤0.01% 6343
2024
Q3 		$2K Sell
275
-472
-63% -$2K ﹤0.01% 6637
2024
Q2 		$2K Sell
747
-18
-2% -$63 ﹤0.01% 6721
2024
Q1 		$3K Sell
765
-1,866
-71% -$8.15K ﹤0.01% 6588
2023
Q4 		$12K Buy
+2,631
New +$10.5K ﹤0.01% 6448
2023
Q3 		– Sell
-4,881
Closed -$17K – 7208
2023
Q2 		$17K Buy
4,881
+4,511
+1,219% +$16.6K ﹤0.01% 6281
2023
Q1 		$1K Buy
+370
New +$1.35K ﹤0.01% 6882
2022
Q4 		– Sell
-49
Closed – – 7354
2022
Q3 		$0 Buy
+49
New +$122 ﹤0.01% 7551
2022
Q2 		– Sell
-23
Closed – – 7460
2022
Q1 		$0 Buy
+23
New +$90 ﹤0.01% 7810
2021
Q4 		– Sell
-1,000
Closed -$5K – 7723
2021
Q3 		$5K Sell
1,000
-2,113
-68% -$11K ﹤0.01% 7128
2021
Q2 		$19K Sell
3,113
-57,308
-95% -$425K ﹤0.01% 6585
2021
Q1 		$443K Buy
60,421
+334
+0.6% +$2.85K ﹤0.01% 4292
2020
Q4 		$488K Buy
60,087
+828
+1% +$6.39K ﹤0.01% 4156
2020
Q3 		$469K Sell
59,259
-988
-2% -$6.75K ﹤0.01% 3914
2020
Q2 		$328K Sell
60,247
-5,002
-8% -$24.8K ﹤0.01% 4095
2020
Q1 		$268K Buy
65,249
+1,032
+2% +$6.02K ﹤0.01% 4118
2019
Q4 		$462K Buy
64,217
+63,111
+5,706% +$390K ﹤0.01% 4045
2019
Q3 		$7K Buy
+1,106
New +$7.06K ﹤0.01% 5890

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Royal Bank of Canada's ETON Position: Q1 2026 in Review

Royal Bank of Canada reduced its Eton Pharmaceutcials (ETON) stake by 99% in Q1 2026, selling an estimated $17.6K and leaving 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7277.

Royal Bank of Canada first reported a position in ETON in Q3 2019 and has held it in 23 quarters since. The position peaked at $10.4M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Royal Bank of Canada held 13 shares of Eton Pharmaceutcials worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 1,005 Eton Pharmaceutcials shares in Q1 2026, an estimated $17.6K.
  • Eton Pharmaceutcials made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7277 holding.
  • Royal Bank of Canada first reported a position in Eton Pharmaceutcials in Q3 2019 and has held it in 23 quarters since.
  • Royal Bank of Canada's Eton Pharmaceutcials position peaked at $10.4M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.